MacroGenics Current Ratio 2012-2019 | MGNX

MacroGenics current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
MacroGenics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.34B $0.05B 6.47
2018-12-31 $0.27B $0.06B 4.49
2018-09-30 $0.29B $0.05B 5.95
2018-06-30 $0.32B $0.05B 6.71
2018-03-31 $0.27B $0.05B 5.43
2017-12-31 $0.32B $0.05B 6.48
2017-09-30 $0.21B $0.03B 6.46
2017-06-30 $0.25B $0.03B 8.37
2017-03-31 $0.25B $0.03B 9.45
2016-12-31 $0.28B $0.03B 10.40
2016-09-30 $0.32B $0.02B 14.34
2016-06-30 $0.35B $0.02B 17.84
2016-03-31 $0.31B $0.02B 17.37
2015-12-31 $0.34B $0.02B 14.15
2015-09-30 $0.37B $0.02B 16.55
2015-06-30 $0.24B $0.02B 10.17
2015-03-31 $0.27B $0.02B 11.13
2014-12-31 $0.17B $0.03B 6.08
2014-09-30 $0.19B $0.03B 7.19
2014-06-30 $0.20B $0.03B 6.65
2014-03-31 $0.20B $0.03B 6.89
2013-12-31 $0.12B $0.03B 4.15
2013-09-30 $0.04B $0.03B 1.46
2013-06-30 $0.04B $0.03B 1.35
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.06B $0.04B 1.33
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.742B $0.060B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.709B 28.48
Medtronic (MDT) Ireland $133.941B 19.13
Stryker (SYK) United States $76.636B 27.35
Boston Scientific (BSX) United States $58.213B 27.91
Baxter (BAX) United States $41.870B 26.39
EssilorLuxottica Societe Anonyme (ESLOY) France $28.961B 0.00
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.277B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.004B 16.06
Terumo (TRUMY) Japan $22.862B 26.29
Smith & Nephew SNATS (SNN) United Kingdom $19.073B 0.00
ResMed (RMD) United States $17.690B 33.80
Canopy Growth (CGC) Canada $12.296B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.220B 48.88
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Aurora Cannabis (ACB) Canada $7.261B 71.60
Insulet (PODD) United States $7.142B 520.35
Hill-Rom Holdings (HRC) United States $7.099B 21.52
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.283B 51.28
ICU Medical (ICUI) United States $5.126B 30.59
GW Pharmaceuticals (GWPH) United Kingdom $5.014B 0.00
Neogen (NEOG) United States $3.340B 54.31
Hutchison China MediTech (HCM) China $2.954B 0.00
NuVasive (NUVA) United States $2.945B 24.05
Agios Pharmaceuticals (AGIO) United States $2.762B 0.00
National Vision Holdings (EYE) United States $2.459B 52.40
Quidel (QDEL) United States $2.264B 23.50
Aphria (APHA) $1.581B 0.00
Cardiovascular Systems (CSII) United States $1.532B 879.80
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.186B 0.00
VAREX IMAGING (VREX) United States $1.172B 24.87
Lantheus Holdings (LNTH) United States $1.081B 28.70
NanoString Technologies (NSTG) United States $1.069B 0.00
PetIQ (PETQ) United States $1.001B 24.32
Quanterix (QTRX) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Cerus (CERS) United States $0.757B 0.00
Omeros (OMER) United States $0.747B 0.00
TG Therapeutics (TGTX) United States $0.693B 0.00
LeMaitre Vascular (LMAT) United States $0.583B 28.24
Surmodics (SRDX) United States $0.531B 77.12
OraSure Technologies (OSUR) United States $0.527B 24.26
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.393B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.53
BioLife Solutions (BLFS) United States $0.311B 97.35
Zynex (ZYXI) United States $0.239B 24.53
Cytosorbents (CTSO) United States $0.232B 0.00
Bovie Medical (APYX) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.192B 4.07
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Female Health (VERU) United States $0.147B 0.00
Fonar (FONR) United States $0.137B 7.22
Chembio Diagnostics (CEMI) United States $0.101B 0.00
United-Guardian (UG) United States $0.094B 20.60
InfuSystems Holdings (INFU) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 21.58
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00